Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial

Xue Chen; Xiuping Han; Bo Cheng; Hui Li; Lingling Liu; Songmei Geng; Linfeng Li; Jie Li; Qing Guo; Guoyi Zhang; Hong Fang; Jianzhong Zhang

doi:10.1097/CM9.0000000000003071

Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial

Xue Chen
, Xiuping Han
, Bo Cheng
, Hui Li
, Lingling Liu
, Songmei Geng
, Linfeng Li
, Jie Li
, Qing Guo
, Guoyi Zhang
, Hong Fang
, Jianzhong Zhang

Peking University
China Medical University
Fujian Medical University
First Affiliated Hospital of Chongqing Medical University
The Second Affiliated Hospital of Xi'an Jiaotong University
Capital Medical University
Central South University
Sun Yat-Sen University
Chinese Academy of Medical Sciences
Zhejiang University

科研成果: 期刊稿件 › 快报 › 同行评审

4 引用（Scopus）

源语言	英语
页（从-至）	1480-1482
页数	3
期刊	Chinese Medical Journal
卷	137
期	12
DOI	https://doi.org/10.1097/CM9.0000000000003071
出版状态	已出版 - 20 6月 2024
已对外发布	是

访问文件

10.1097/CM9.0000000000003071

其它文件与链接

链接到 Scopus 的出版物

引用此

Chen, X., Han, X., Cheng, B., Li, H., Liu, L., Geng, S., Li, L., Li, J., Guo, Q., Zhang, G., Fang, H., & Zhang, J. (2024). Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial. Chinese Medical Journal, 137(12), 1480-1482. https://doi.org/10.1097/CM9.0000000000003071

@article{f6f65e6531fa4835a56120e887ddfe5b,

title = "Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial",

author = "Xue Chen and Xiuping Han and Bo Cheng and Hui Li and Lingling Liu and Songmei Geng and Linfeng Li and Jie Li and Qing Guo and Guoyi Zhang and Hong Fang and Jianzhong Zhang",

year = "2024",

month = jun,

day = "20",

doi = "10.1097/CM9.0000000000003071",

language = "英语",

volume = "137",

pages = "1480--1482",

journal = "Chinese Medical Journal",

issn = "0366-6999",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

Chen, X, Han, X, Cheng, B, Li, H, Liu, L, Geng, S, Li, L, Li, J, Guo, Q, Zhang, G, Fang, H & Zhang, J 2024, 'Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial', Chinese Medical Journal, 卷 137, 号码 12, 页码 1480-1482. https://doi.org/10.1097/CM9.0000000000003071

Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial. / Chen, Xue; Han, Xiuping; Cheng, Bo 等.
在: Chinese Medical Journal, 卷 137, 号码 12, 20.06.2024, 页码 1480-1482.

科研成果: 期刊稿件 › 快报 › 同行评审

TY - JOUR

T1 - Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria

T2 - A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial

AU - Chen, Xue

AU - Han, Xiuping

AU - Cheng, Bo

AU - Li, Hui

AU - Liu, Lingling

AU - Geng, Songmei

AU - Li, Linfeng

AU - Li, Jie

AU - Guo, Qing

AU - Zhang, Guoyi

AU - Fang, Hong

AU - Zhang, Jianzhong

PY - 2024/6/20

Y1 - 2024/6/20

UR - https://www.scopus.com/pages/publications/85196767016

U2 - 10.1097/CM9.0000000000003071

DO - 10.1097/CM9.0000000000003071

M3 - 快报

C2 - 38557589

AN - SCOPUS:85196767016

SN - 0366-6999

VL - 137

SP - 1480

EP - 1482

JO - Chinese Medical Journal

JF - Chinese Medical Journal

IS - 12

ER -